Validation of a method for the simultaneous quantification of chloroquine, desethylchloroquine and primaquine in plasma by HPLC-DAD

Journal of Pharmaceutical and Biomedical Analysis

Volumn 95, Issue , 2014, Pages 200-206

  Zuluaga Idárraga, Lina ^a   Yepes Jiménez, Natalia ^a   López Córdoba, Carlos ^a   Blair Trujillo, Silvia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Chloroquine; Drug plasma level; Effective therapeutic concentration; High performance liquid chromatography (HPLC); Malaria vivax; Primaquine

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE; PRIMAQUINE;

ACCURACY; ARTICLE; CALIBRATION; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIODE ARRAY DETECTOR; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; STORAGE; ULTRAVIOLET DETECTOR; VALIDATION PROCESS; ANALOGS AND DERIVATIVES; BLOOD; MALARIA, VIVAX; PROCEDURES; VALIDATION STUDY;

CALIBRATION; CHLOROQUINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; MALARIA, VIVAX; PRIMAQUINE;

EID: 84896991180     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.03.006     Document Type: Article

References (41)

1. WHO, World Malaria Report: 2013, 2014.
2. Guerra C.A., Howes R.E., Patil A.P., Gething P.W., Van Boeckel T.P., Temperley W.H., Kabaria C.W., Tatem A.J., Manh B.H., Elyazar I.R. The international limits and population at risk of Plasmodium vivax transmission. PLoS Negl. Trop. Dis. 2010, 4:e774.
3. Anstey N.M., Russell B., Yeo T.W., Price R.N. The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25:220-227.
4. White N. The parasite clearance curve. Malar. J. 2011, 10:278.
5. Baird J.K. Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 2009, 22:508-534.
6. WHO, Guidelines for treatment of malaria, 2010.
7. WHO, Methods for surveillance of antimalarial drug efficacy, 2009.
8. Adelusi S.A., Dawodu A.H., Salako L.A. Kinetics of the uptake and elimination of chloroquine in children with malaria. Br. J. Clin. Pharmacol. 1982, 14:483-487.
9. Gustafsson L.L., Walker O., Alvan G., Beermann B., Estevez F., Gleisner L., Lindstrom B., Sjoqvist F. Disposition of chloroquine in man after single intravenous and oral doses. Br. J. Clin. Pharmacol. 1983, 15:471-479.
10. Walker O., Dawodu A.H., Adeyokunnu A.A., Salako L.A., Alvan G. Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br. J. Clin. Pharmacol. 1983, 16:701-705.
11. Cuong B.T., Binh V.Q., Dai B., Duy D.N., Lovell C.M., Rieckmann K.H., Edstein M.D. Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?. Br. J. Clin. Pharmacol. 2006, 61:682-689.
12. Mihaly G., Ward S., Edwards G., Orme M., Breckenridge A. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br. J. Clin. Pharmacol. 1984, 17:441-446.
13. Akintonwa A., Meyer M.C., Hwang P.T.R. Simultaneous determination of chloroquine and desethylchloroquine in blood, plasma, and urine by high-performance liquid chromatography. J. Liquid Chromatogr. 1983, 6:1513-1522.
14. Bergqvist Y., Frisk-Holmberg M. Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatography. J. Chromatogr. 1980, 221:119-127.
15. Cheomung A., Na-Bangchang K. HPLC with ultraviolet detection for the determination of chloroquine and desethylchloroquine in whole blood and finger-prick capillary blood dried on filter paper. J. Pharm. Biomed. Anal. 2011, 55:1031-1040.
16. Dua V.K., Kar P., Gupta N., Sharma V. Determination of chloroquine and desethylchloroquine in plasma and blood cells of Plasmodium vivax malaria cases using liquid chromatography. J. Pharm. Biomed. Anal. 1999, 21:199-205.
17. Ducharme J., Farinotti R. Rapid and simple method to determine chloroquine and its desethylated metabolites in human microsomes by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 1997, 698:243-250.
18. Lindström B., Ericsson Ö., Alván G., Rombo L., Ekman L., Rais M., Sjoqvist F. Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper. Ther. Drug. Monit. 1985, 7:207-210.
19. Minzi O., Rais M., Svensson J., Gustafsson L., Ericsson O. High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2003, 783:473-480.
20. Patchen L.C., Mount D.L., Schwartz I.K., Churchill F.C. Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 1983, 278:81-89.
21. Samanidou V.F., Evaggelopoulou E.N., Papadoyannis I.N. Simultaneous determination of quinine and chloroquine anti-malarial agents in pharmaceuticals and biological fluids by HPLC and fluorescence detection. J. Pharm. Biomed. Anal. 2005, 38:21-28.
22. Añez A., Suárez M.F., Cuba J. Factores que retardan el diagnóstico y el tratamiento de la malaria en el municipio de Riberalta, Bolivia. Biomedica 2012, 32:38-45.
23. Baird J.K., Leksana B., Masbar S., Fryaufe D., Sutanihardja M.A., Wignall F.S., Hoffman S.L. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 1997, 56:621-626.
24. Baird J.K., Leksana B., Masbar S., Sutanihardja M.A., Fryauff D.J., Subianto B. Whole blood chloroquine concentrations with Plasmodium vivax infection in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 1997, 56:618.
25. Rombo L., Ericsson Ö., Alvän G., Lindström B., Gustafsson L.L., Sjöqvist F. Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther. Drug. Monit. 1985, 7:211-215.
26. Endoh Y.S., Yoshimura H., Sasaki N., Ishihara Y., Sasaki H., Nakamura S., Inoue Y., Nishikawa M. High-performance liquid chromatographic determination of pamaquine, primaquine and carboxy primaquine in calf plasma using electrochemical detection. J. Chromatogr. 1992, 579:123-129.
27. Nitin M., Rajanikanth M., Lal J., Madhusudanan K., Gupta R. Liquid chromatography-tandem mass spectrometric assay with a novel method of quantitation for the simultaneous determination of bulaquine and its metabolite, primaquine, in monkey plasma. J. Chromatogr. B. 2003, 793:253-263.
28. Page-Sharp M., Ilett K.F., Betuela I., Davis T.M., Batty K.T. Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC-MS assay. J. Chromatogr. B 2012, 902:142-146.
29. Ward S., Edwards G., Orme M.L.E., Breckenridge A. Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography. J. Chromatogr. 1984, 305:239-243.
30. Dua V., Kar P., Sarin R., Sharma V. High-performance liquid chromatographic determination of primaquine and carboxyprimaquine concentrations in plasma and blood cells in Plasmodium vivax malaria cases following chronic dosage with primaquine. J. Chromatogr. B Biomed. Appl. 1996, 675:93-98.
31. Mihaly G., Ward S., Edwards G., Nicholl D., Orme M., Breckenridge A. Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br. J. Clin. Pharmacol. 1985, 19:745-750.
32. Ward S., Mihaly G., Edwards G., Looareesuwan S., Phillips R., Chanthavanich P., Warrell D., Orme M., Breckenridge A. Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects. Br. J. Clin. Pharmacol. 1985, 19:751-755.
33. Kim Y.R., Kuh H.J., Kim M.Y., Kim Y.S., Chung W.C., Kim S.I., Kang M.W. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria. Arch. Pharm. Res. 2004, 27:576-580.
34. H.M. Staines, S. Krishna, Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use, 2012.
35. Dwivedi A., Saxena D., Singh S. HPLC and HPTLC assays for the antimalarial agents Chloroquine, Primaquine and Bulaquine. J. Pharm. Biomed. Anal. 2003, 33:851-858.
36. Nowatzke W., Woolf E. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples. AAPS J. 2007, 9:E117-E122.
37. EMA, Guideline on bioanalytical method validation, 2011.
38. FDA, Guidance for Industry: Bioanalytical Method Validation, 2001.
39. Miller A.K., Harrell E., Ye L., Baptiste-Brown S., Kleim J.P., Ohrt C., Duparc S., Mohrle J.J., Webster A., Stinnett S., Hughes A., Griffith S., Beelen A.P. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. Br. J. Clin. Pharmacol. 2013, 76:858-867.
40. Rengelshausen J., Burhenne J., Frohlich M., Tayrouz Y., Singh S.K., Riedel K.D., Muller O., Hoppe-Tichy T., Haefeli W.E., Mikus G., Walter-Sack I. Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur. J. Clin. Pharmacol. 2004, 60:709-715.
41. Elmes N.J., Bennett S.M., Abdalla H., Carthew T.L., Edstein M.D. Lack of sex effect on the pharmacokinetics of primaquine. Am. J. Trop. Med. Hyg. 2006, 74:951-952.